Skip to content

Telemedicine Education for Caregivers and Asthma Control in Children

Effectiveness of Telemedicine-Based Education for Caregivers on Asthma Control in Children With Uncontrolled Asthma: A Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06753214
Acronym
TCARE
Enrollment
64
Registered
2024-12-31
Start date
2024-06-05
Completion date
2026-06-30
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Telemedicine-Based Education, Uncontrolled Asthma

Keywords

Asthma, Pediatrics, Telemedicine, Uncontrolled asthma

Brief summary

Asthma control in pediatric patients remains a critical issue for healthcare providers. Telemedicine has emerged as an effective solution for overcoming distance barriers in healthcare delivery. This study aims to utilize telemedicine-based education for caregivers to improve asthma control in children with uncontrolled asthma. By providing remote guidance and support, the study seeks to enhance caregivers' knowledge and management practices, ultimately leading to better asthma outcomes for pediatric patients.

Interventions

OTHERTelemedicine-Based Education

Intervention through telemedicine

OTHERStandard Care (in control arm)

Sham comparator through telemedicine

Sponsors

Can Tho University of Medicine and Pharmacy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
4 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Pediatric asthma patients diagnosed according to the GINA guidelines, classified as having uncontrolled asthma, are managed and followed up for at least 1 month at the pediatric asthma unit of the outpatient department.

Exclusion criteria

* Pediatric patients who do not cooperate or are unable to complete the Childhood Asthma Control Test questionnaire. * Caregivers who cannot complete the questionnaires related to the assessment of asthma control and associated factors. * Pediatric patients who have siblings participating in the study. * Patients currently participating in another clinical study (excluding non-interventional studies or registries). * Failure to return for a second visit within 6 months following enrollment.

Design outcomes

Primary

MeasureTime frameDescription
The improvement of asthma controlAt second follow-up visit (ranging from 4 to 24 weeks after enrollment)The patients will be evaluated for asthma control using the Childhood Asthma Control Test (C-ACT) for children aged 4-11 or Asthma Control Test (ACT) for children aged 12 and older. This evaluation will also be compared to the baseline to determine whether there is improvement after the intervention period.

Secondary

MeasureTime frameDescription
The improvement of caregiver's knowledge regarding asthma controlAt second follow-up visit (ranging from 4 to 24 weeks after enrollment)The caregiver's knowledge regarding asthma will be assessed using a validated questionnaire. This evaluation will also be compared to the baseline to determine whether there is improvement after the intervention period.
The improvement of caregiver's attitudes toward asthma managementAt second follow-up visit (ranging from 4 to 24 weeks after enrollment)Caregiver's attitudes toward asthma management will be assessed using a set of questions designed to evaluate their perspectives on key aspects of asthma care, including the importance of regular doctor visits, adherence to controller medications, following prescription instructions, proper cleaning of inhaler devices, and mouth rinsing after inhaler use. The evaluation will be compared to baseline data to determine whether there is an improvement in caregivers' attitudes after the intervention period.
The improvement of proper inhaler technique usageAt second follow-up visit (ranging from 4 to 24 weeks after enrollment)The patients will be evaluated on their proper inhaler use technique using a consistent checklist. This evaluation will be compared to the baseline to determine whether there is any improvement after the intervention period.

Countries

Vietnam

Contacts

Primary ContactThang Hoang Le, MD
hoangthang0899@gmail.com+84962024776
Backup ContactLy Cong Tran, MD, MSc
tcly@ctump.edu.vn+84397938208

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026